Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Apr 7;152(7):1675–1689. doi: 10.1093/jn/nxac084

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2022. Published by Oxford University Press on behalf of the American Society for Nutrition.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

PMC Copyright notice

Cross-sectional comparisons of plasma VLDL subfractions measured by NMR in young (n = 30) and older (n = 54) adults (left column), and the effects of 6 mo of placebo (n = 22, middle column) and n–3-PUFA supplementation (n = 22, right column) on triglycerides (A), esterified cholesterol (B), free cholesterol (C), and phospholipids (D). VLDL particles are numbered 1–4 in order of increasing density and decreasing size. A total of 5 participants dropped out after randomization (2 placebo, 3 n–3 PUFA). Data are shown as mean ± SD. *Significant (P value < 0.05) differences between young and older adults observed at baseline. ^ΩSignificant differences between treatment groups found by ANCOVA.